Cooper Companies to acquire PARAGARD IUD from Teva for $1.1 billion

The Cooper Companies has entered into a definitive agreement to acquire the global rights and business of Teva's PARAGARD Intrauterine Device for $1.1 billion in cash. The deal includes Teva's manufacturing facility in Buffalo, NY.

“The Cooper Companies, Inc. today announced it has entered into a definitive asset purchase agreement with Teva Pharmaceutical Industries Ltd. to acquire the global rights and business of its PARAGARD Intrauterine Device in a $1.1 billion cash transaction”investor.coopercos.com

• 1 source
• investor.coopercos.comThe Cooper Companies Announces Definitive Agreement to Acquire PARAGARD® IUD From Teva - CooperCompaniesSep 11, 2017

Summarized from public sources; check the original articles before acting on it.